Skip to main content
Clinical Trials/NCT04786808
NCT04786808
Terminated
Not Applicable

Risk Factors for COVID-19 Mortality: a Prospective Observational Study

Teodoro Marcianò1 site in 1 country200 target enrollmentJanuary 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19 Virus Infection
Sponsor
Teodoro Marcianò
Enrollment
200
Locations
1
Primary Endpoint
Mortality rate
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

COVID-19 pandemic has deeply burdened hospitals all over the world. A two-stage disease has been hypothesized due to quick worsening of clinical status after 7-10 days from the beginning of first symptoms, generally flu-like symptoms. Predicting clinical worsening could help to address major efforts towards higher risk patients.

During the last year most observational studies, generally retrospective, has been conducted, identifying some risk factors such as age, obesity, male gender, cardiovascular disease, COPD, diabetes etc.

The study goal is to collect systematically a variegate amount of clinical, biometric, laboratory and radiological data from patients admitted to the Emergency Medicine Ward of Piacenza Hospital (Italy), in order to prospectively analyze what characteristics are associated to higher risk of mortality.

Registry
clinicaltrials.gov
Start Date
January 15, 2021
End Date
November 7, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Teodoro Marcianò
Responsible Party
Sponsor Investigator
Principal Investigator

Teodoro Marcianò

Doctor of Medicine, Emergency Medicine Specialist

Azienda Unità Sanitaria Locale di Piacenza

Eligibility Criteria

Inclusion Criteria

  • Admission to the Emergency Medicine Ward from the Emergency Department of Piacenza Hospital (Italy)
  • Confirmed COVID-19 diagnosis through molecular test obtained from nasal-pharyngeal swabs in the Emergency Department
  • Age above 18

Exclusion Criteria

  • inability to obtain an informed consent due to neurological conditions.
  • patient's refusal to sign the informed consent
  • inability of researchers to recruit the patient in the first 24 hours from the admission.

Outcomes

Primary Outcomes

Mortality rate

Time Frame: 28 days after admission

Number of patients who die for any cause in the first 28 days after admission

Secondary Outcomes

  • Need of invasive ventilation(15 days after admission)

Study Sites (1)

Loading locations...

Similar Trials